| 2025 | 2024 | 2023 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 606,6 k € | — | — | — | — | — | — | — | 4,4 k € | — | — | — | — | — | — | — | ||||||||||||||||
| Gross margin | — | — | — | — | — | — | — | — | — | 82,7 k € | +104.7% | -1,8 M € | -3.5% | -1,7 M € | +34.6% | -2,6 M € | -26.7% | -2,1 M € | +4.8% | -2,2 M € | -90.9% | -1,1 M € | ||||||||||
| EBITDA | -113,3 k € | +67.5% | -348,9 k € | -20.8% | -288,9 k € | +70.3% | -973,3 k € | +63.8% | -2,7 M € | -8.1% | -2,5 M € | -131.5% | -1,1 M € | +51.1% | -2,2 M € | -14.2% | -1,9 M € | -246.1% | -555,7 k € | +75.6% | -2,3 M € | +1.7% | -2,3 M € | +27.0% | -3,2 M € | -22.4% | -2,6 M € | +1.8% | -2,6 M € | -63.8% | -1,6 M € | |
| Operating profit | -113,3 k € | -369.8% | 42,0 k € | +114.5% | -288,9 k € | +73.6% | -1,1 M € | +94.0% | -18,2 M € | -17.6% | -15,5 M € | -11.0% | -14,0 M € | +15.0% | -16,5 M € | -312.1% | -4,0 M € | -213.5% | -1,3 M € | +44.7% | -2,3 M € | +1.5% | -2,3 M € | +28.3% | -3,3 M € | -16.7% | -2,8 M € | +6.2% | -3,0 M € | -43.2% | -2,1 M € | |
| Profit/loss | 338,5 k € | +101.0% | 168,4 k € | +927.9% | -20,3 k € | +98.4% | -1,3 M € | +92.9% | -17,7 M € | -15.2% | -15,3 M € | -17.2% | -13,1 M € | +18.3% | -16,0 M € | -295.9% | -4,0 M € | -191.9% | -1,4 M € | +40.2% | -2,3 M € | -0.8% | -2,3 M € | +29.8% | -3,3 M € | -19.9% | -2,7 M € | -0.9% | -2,7 M € | -68.4% | -1,6 M € | |
| Equity | 45,9 M € | +0.7% | 45,6 M € | +0.4% | 45,4 M € | +918.2% | -5,6 M € | -30.1% | -4,3 M € | -146.1% | 9,3 M € | +73.5% | 5,3 M € | -71.2% | 18,5 M € | +199.0% | 6,2 M € | -39.5% | 10,2 M € | +165688.2% | 6,2 k € | -99.7% | 2,3 M € | +31.2% | 1,8 M € | +159.4% | 682,0 k € | -80.7% | 3,5 M € | +2.2% | 3,5 M € | |
| Total assets | 46,7 M € | +0.4% | 46,5 M € | -1.2% | 47,1 M € | +806.3% | 5,2 M € | -25.4% | 7,0 M € | -46.8% | 13,1 M € | +59.2% | 8,2 M € | -60.1% | 20,6 M € | +64.5% | 12,5 M € | +10.1% | 11,4 M € | +753.2% | 1,3 M € | -48.6% | 2,6 M € | +13.5% | 2,3 M € | +83.9% | 1,2 M € | -70.5% | 4,2 M € | +8.7% | 3,9 M € | |
| Cash | 376,8 k € | +695.8% | 47,3 k € | -88.7% | 420,2 k € | -85.3% | 2,9 M € | -21.9% | 3,6 M € | -56.9% | 8,5 M € | +299.2% | 2,1 M € | -84.2% | 13,4 M € | +190.0% | 4,6 M € | -45.1% | 8,4 M € | +598.1% | 1,2 M € | -51.4% | 2,5 M € | +24.1% | 2,0 M € | +125.7% | 883,4 k € | -75.8% | 3,7 M € | +3514.9% | 101,0 k € | |
| Debts | 802,2 k € | -15.3% | 946,9 k € | -25.4% | 1,3 M € | -88.0% | 10,6 M € | -4.4% | 11,1 M € | +188.9% | 3,8 M € | +32.8% | 2,9 M € | +39.5% | 2,1 M € | -66.7% | 6,2 M € | +526.4% | 994,6 k € | -25.0% | 1,3 M € | +385.8% | 273,0 k € | -47.1% | 515,6 k € | -4.6% | 540,2 k € | -13.6% | 625,5 k € | +57.8% | 396,3 k € | |
| Staff | — | — | — | 2,7 | 16,4 | 19 | 21,9 | 19,5 | 16,3 | 10,2 | 8,2 | 10,2 | 10,3 | 9,1 | 8,5 | 8,8 | ||||||||||||||||
Public limited company · Ixelles · incorporated on 05/06/1997
Public limited company profitable and well capitalised. Cash position rising (+695.8%).
Solid counterparty for a standard engagement.
European Medical Solutions is a Public limited company incorporated in 1997. Its main activity is: Manufacture of other chemical products n.e.c.. Its registered office is in Ixelles.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette